Portfolio company
AMR Bio
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops topical antimicrobial gels to prevent post-surgical infections for healthcare providers and patients undergoing surgery.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Amprologix
This biotechnology company develops novel antibiotics to treat antimicrobial-resistant bacterial infections for patients with conditions including MRSA and related skin and wound infections.
Amferia
This company produces antimicrobial hydrogel wound dressings for human healthcare and veterinary markets to combat antibiotic-resistant bacterial infections.
MetalloBio
This company develops antimicrobial compounds and medical device coatings to combat antibiotic resistance for the pharmaceutical and healthcare sectors.
TYBR Health
This company develops a hydrogel system for orthopaedic surgeons to protect tendons and ligaments from internal scarring following surgical procedures.
LAM-X
This company develops light-activated antimicrobial nanofibre materials for wound care, medical device dressings and life science research applications for patients and healthcare providers.
DEBx Medical
This company develops chemical debridement agents for healthcare professionals to treat chronic wounds by removing infection and biofilm.
TYRX
This company develops antibacterial mesh envelopes for implanted medical devices to reduce surgical-site infections for cardiac and neurological patients.
Zonova
Zonova develops antimicrobial technology embedded into medical device polymers to prevent healthcare-acquired infections for medical device manufacturers and clinicians.
